USPTO serial 76568020
CHONDROGENE
Reviewed by CopyMark Law Group
Reg. 3678147Status 710
- Filing date
- Status date
- Registration date
- Sep 8, 2009
- Examiner
- POWERS, ALEXANDER L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with CHONDROGENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Toronto M3J 3K4 Ontario, CA
Richmond Hill, CA
Richmond Hill, CA
Richmond Hill, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew S. Ehard
ANDREW S. EHARD MERCHANT & GOULD P.C.PO BOX 2910MINNEAPOLIS, MN 55402-0910UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | (Based on Use in Commerce) (Based on 44(e)) Diagnostic preparations, namely, preparations of extracts and nucleic acids, namely, RNA, and cDNA clones for medical research and development use; (Based on 44(e)) Diagnostic assays and test kits for use in laboratory, medical research and chemical research and development; diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, proteins and antibodies, and molecular arrays of biological material for medical research use | SECTION 8 - CANCELLED | Jan 7, 2003 |
| 005 | (Based on 44(e)) Diagnostic assays and test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for use to diagnose, prognose or predict diseases; prognostic test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins,antibodies and molecular arrays of biological material, for identifying disease risk factors and responses to therapeutic treatment; diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies,and molecular arrays of biological material for clinical or medical use; diagnostic preparations, namely, preparations of extracts and nucleic acids, namely, RNA and cDNA clones for clinical use | SECTION 8 - CANCELLED | — |
| 042 | (Based on Use in Commerce) (Based on 44(e)) Research and development, validation testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology and genomics; (Based on 44(e)) Research and development, validation testing, data analysis and product development in the fields of pharmacogenomics, toxicogenomics and personalized medicine; Evaluation of clinical trial progress, and drug monitoring and monitoring of patient health progression as it relates to experimental research | SECTION 8 - CANCELLED | Jul 18, 2001 |
| 044 | (Based on 44(e)) Diagnostic services, namely, diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ChondroGene Limited
- Other trademarks owned by GENENEWS LIMITED
- Other trademarks owned by GENENEWS LIMITED
- Other trademarks owned by GENENEWS LIMITED
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CHONDROGENE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 15, 2016 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Sep 8, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 3, 2009 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Aug 3, 2009 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 3, 2009 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Jul 30, 2009 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jun 17, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 16, 2009 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jun 16, 2009 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Dec 23, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 30, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 10, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 28, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 28, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 28, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Aug 27, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 27, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 25, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 25, 2008 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 15, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 14, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 14, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 14, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 7, 2008 | PAPER RECEIVED | — | |
| Mar 19, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 21, 2007 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 20, 2007 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 20, 2007 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 11, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 11, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 31, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 31, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 22, 2007 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 6, 2007 | PAPER RECEIVED | — | |
| Apr 18, 2007 | CPRA | PRIORITY ACTION MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Apr 18, 2007 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 2, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 1, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 11, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jan 11, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 11, 2007 | ALIE | ASSIGNED TO LIE | — |
| Dec 8, 2006 | PAPER RECEIVED | — | |
| Sep 18, 2006 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Sep 15, 2006 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 15, 2006 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 5, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 5, 2006 | PAPER RECEIVED | — | |
| Jun 20, 2006 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 20, 2006 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 13, 2006 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Mar 12, 2006 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 12, 2005 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Sep 9, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 9, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 16, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 16, 2005 | PAPER RECEIVED | — | |
| Mar 23, 2005 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Mar 23, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 23, 2005 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 14, 2005 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Mar 13, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 23, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Feb 3, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jan 31, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 31, 2005 | PAPER RECEIVED | — | |
| Aug 19, 2004 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |
| Aug 19, 2004 | FAXX | FAX RECEIVED | — |
| Aug 2, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 20, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 14, 2004 | NWAP | NEW APPLICATION ENTERED | — |